Abbott Laboratories
ABT
$128.54
$0.490.38%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.37% | 5.85% | 5.00% | 4.59% | 3.15% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.37% | 5.85% | 5.00% | 4.59% | 3.15% |
| Cost of Revenue | 5.97% | 4.44% | 3.74% | 4.55% | 1.73% |
| Gross Profit | 6.69% | 7.00% | 6.03% | 4.62% | 4.30% |
| SG&A Expenses | 5.28% | 5.51% | 6.03% | 7.15% | 3.19% |
| Depreciation & Amortization | -8.92% | -7.55% | -6.21% | -4.48% | -4.39% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.26% | 4.53% | 4.25% | 5.17% | 1.86% |
| Operating Income | 11.41% | 11.96% | 8.54% | 1.94% | 9.41% |
| Income Before Tax | 20.06% | 21.34% | 12.50% | 5.24% | 9.52% |
| Income Tax Expenses | -677.55% | -738.76% | -776.98% | -778.96% | -1.56% |
| Earnings from Continuing Operations | 142.36% | 151.56% | 139.82% | 134.18% | 11.72% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 142.36% | 151.56% | 139.82% | 134.18% | 11.72% |
| EBIT | 11.41% | 11.96% | 8.54% | 1.94% | 9.41% |
| EBITDA | 7.10% | 7.25% | 5.16% | 1.10% | 6.25% |
| EPS Basic | 141.77% | 151.22% | 140.18% | 134.53% | 12.22% |
| Normalized Basic EPS | 12.20% | 13.14% | 9.25% | 1.80% | 9.07% |
| EPS Diluted | 142.48% | 151.67% | 140.16% | 134.63% | 12.03% |
| Normalized Diluted EPS | 12.22% | 13.16% | 9.14% | 1.70% | 8.99% |
| Average Basic Shares Outstanding | 0.00% | -0.03% | -0.13% | -0.14% | -0.20% |
| Average Diluted Shares Outstanding | -0.04% | -0.08% | -0.06% | -0.05% | -0.11% |
| Dividend Per Share | 7.27% | 7.41% | 7.55% | 7.69% | 7.84% |
| Payout Ratio | -0.56% | -0.57% | -0.55% | -0.54% | -0.03% |